These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

223 related items for PubMed ID: 15351803

  • 1. [Health economics analysis of colorectal screening].
    Boncz I, Sebestyén A, Dózsa C, Pál M, Sándor J, Palásti J, Betlehem J, Ember I.
    Magy Onkol; 2004; 48(2):111-5. PubMed ID: 15351803
    [Abstract] [Full Text] [Related]

  • 2. [Health economics analysis of breast cancer screening].
    Boncz I, Sebestyén A, Gulácsi L, Pál M, Dózsa C.
    Magy Onkol; 2003; 47(2):149-54. PubMed ID: 12975661
    [Abstract] [Full Text] [Related]

  • 3. [Health economics analysis of cervical cancer screening].
    Boncz I, Sebestyén A, Pál M, Sándor J, Ember I.
    Orv Hetil; 2003 Apr 13; 144(15):713-7. PubMed ID: 12774432
    [Abstract] [Full Text] [Related]

  • 4. Effect of screening for cancer in the Nordic countries on deaths, cost and quality of life up to the year 2017.
    Hristova L, Hakama M.
    Acta Oncol; 1997 Apr 13; 36 Suppl 9():1-60. PubMed ID: 9143316
    [Abstract] [Full Text] [Related]

  • 5. Effectiveness and economic impact of screening for colorectal cancer by mass fecal occult blood testing.
    Helm JF, Russo MW, Biddle AK, Simpson KN, Ransohoff DF, Sandler RS.
    Am J Gastroenterol; 2000 Nov 13; 95(11):3250-8. PubMed ID: 11095350
    [Abstract] [Full Text] [Related]

  • 6. The relevance of unrelated costs internal and external to the healthcare sector to the outcome of a cost-comparison analysis of secondary prevention: the case of general colorectal cancer screening in the German population.
    Tscheulin DK, Drevs F.
    Eur J Health Econ; 2010 Apr 13; 11(2):141-50. PubMed ID: 19449159
    [Abstract] [Full Text] [Related]

  • 7. Cost-saving analysis of screening colonoscopy in Germany.
    Sieg A, Brenner H.
    Z Gastroenterol; 2007 Sep 13; 45(9):945-51. PubMed ID: 17874356
    [Abstract] [Full Text] [Related]

  • 8. Cost-effectiveness analysis of screening for lung cancer with low dose spiral CT (computed tomography) in the Australian setting.
    Manser R, Dalton A, Carter R, Byrnes G, Elwood M, Campbell DA.
    Lung Cancer; 2005 May 13; 48(2):171-85. PubMed ID: 15829317
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Colorectal cancer screening: advice from the Health Council of the Netherlands].
    van Veen W, Mali WP.
    Ned Tijdschr Geneeskd; 2009 May 13; 153():A1441. PubMed ID: 20003552
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Prevention of cervical cancer with screening programme in Branicevo District and cost-effectiveness analysis adjusted to the territory of the Republic of Serbia.
    Perovic S.
    J BUON; 2009 May 13; 14(1):93-6. PubMed ID: 19373953
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Cost-effectiveness analysis of two strategies for mass screening for colorectal cancer in France.
    Berchi C, Bouvier V, Réaud JM, Launoy G.
    Health Econ; 2004 Mar 13; 13(3):227-38. PubMed ID: 14981648
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Assessment of annual health insurance reimbursement for oncology drugs in Hungary].
    Boncz I, Donkáné Verebes E, Oberfrank F, Kásler M.
    Magy Onkol; 2010 Dec 13; 54(4):283-8. PubMed ID: 21163758
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.